Jonaitis, Paulius http://orcid.org/0000-0002-4310-8543
Kupcinskas, Juozas http://orcid.org/0000-0002-8760-7416
Gisbert, Javier P. http://orcid.org/0000-0003-2090-3445
Jonaitis, Laimas http://orcid.org/0000-0001-9086-3675
Article History
Accepted: 12 December 2023
First Online: 10 February 2024
Declarations
:
: No specific funding was used to conduct this review.
: Javier P. Gisbert has served as speaker, consultant, and advisory member for, or has received research funding from, Mayoly, Allergan, Diasorin, Gebro Pharma, and Richen. Paulius Jonaitis, Juozas Kupcinskas and Laimas Jonaitis have declared no conflicts of interest.
: Not applicable.
: Conceptualization: JPG and LJ. Writing—original draft preparation: PJ and LJ. Writing—review and editing: JK, JPG, LJ. Visualization: PJ. Supervision: JK, JPG, LJ. All authors have read and approved the final version of the manuscript.